In another mouse 4T1 metastatic BC model, researchers developed a FAP-targeting immunotoxin αFAP-PE38 to deplete FAP-positive stromal cells, which showed efficacy in suppressing tumor growth [213]. This evidence concerns the gene FAP and breast cancer.